---
title: "Mizuho Securities Sticks to Their Buy Rating for Pulse Biosciences (PLSE)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276443189.md"
description: "Mizuho Securities has maintained a Buy rating on Pulse Biosciences (PLSE) with a price target of $30. Analyst Anthony Petrone, noted for a 7.3% average return and a 50.11% success rate, focuses on the Healthcare sector. Additionally, TipRanks also issued a Buy rating for Pulse Biosciences, while another report from TipRanks reiterated a Hold rating on the same stock."
datetime: "2026-02-20T12:45:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276443189.md)
  - [en](https://longbridge.com/en/news/276443189.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276443189.md)
---

# Mizuho Securities Sticks to Their Buy Rating for Pulse Biosciences (PLSE)

In a report released today, Anthony Petrone from Mizuho Securities reiterated a Buy rating on Pulse Biosciences, with a price target of $30.00.

### President's Day Sale - 70% Off

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, Petrone is a 4-star analyst with an average return of 7.3% and a 50.11% success rate. Petrone covers the Healthcare sector, focusing on stocks such as Pulse Biosciences, Haemonetics, and Dexcom.

In addition to Mizuho Securities, Pulse Biosciences also received a Buy from TipRanks – Google’s Google Medical – Instruments and Supplies in a report issued today. However, on the same day, TipRanks – OpenAI reiterated a Hold rating on Pulse Biosciences (NASDAQ: PLSE).

### Related Stocks

- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PLSE.US](https://longbridge.com/en/quote/PLSE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)

## Related News & Research

- [RBC Capital Sticks to Their Buy Rating for Edwards Lifesciences (EW)](https://longbridge.com/en/news/282768248.md)
- [Is Thermo Fisher (TMO) Quietly Rewiring Its AI Strategy Through New Data and Proteomics Alliances?](https://longbridge.com/en/news/282768343.md)
- [Pulse Biosciences Launches Pivotal NANOPULSE-AF Clinical Study](https://longbridge.com/en/news/281891382.md)
- [Stryker to Acquire Amplitude Vascular Systems](https://longbridge.com/en/news/282548873.md)
- [Novo Nordisk Partners with OpenAI to Boost Drug Development, Delivery](https://longbridge.com/en/news/282641629.md)